Porphyromonas gingivalis
(P.g), a major causative agent of periodontitis, has been linked to atherosclerosis, a chronic inflammatory vascular disease. Recent studies have suggested a link between periodontitis and arterial stiffness, a risk factor for atherosclerosis. However, the mechanisms by which P.g infection contributes to atherogenesis remain elusive. The formation of lipid‐laden macrophage “foam cells” is critically important to development and progression of atherosclerosis. We have obtained evidence that
TRPV
4 (transient receptor potential channel of the vanilloid subfamily 4), a mechanosensitive channel, is a regulator of macrophage foam cell formation both in response to P.g‐derived lipopolysaccharide (Pg
LPS
) or to an increase in matrix stiffness. Importantly, we found that
TRPV
4 activity (Ca
2+
influx) was increased in response to Pg
LPS
. Genetic deletion or chemical antagonism of
TRPV
4 channels blocked Pg
LPS
‐triggered exacerbation of oxidized
LDL
(ox
LDL
)‐mediated foam cell formation. Mechanistically, we found that (1) T
RPV
4 regulated ox
LDL
uptake but not its cell surface binding in macrophages; (2) reduced foam cell formation in
TRPV
4 null cells was independent of expression of
CD
36, a predominant receptor for ox
LDL
, and (3) co‐localization of
TRPV
4 and
CD
36 on the macrophage plasma membrane was sensitive to the increased level of matrix stiffness occurring in the presence of Pg
LPS
. Altogether, our results suggest that
TRPV
4 channels play an essential role in P.g‐induced exacerbation of macrophage foam cell generation through a mechanism that modulates uptake of ox
LDL
.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.